SCHEMBL931934

SCHEMBL931934

Cc1cc(C(=N)c2cccc(Br)c2)cs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1S P09871 1/20 0.47
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
DAO P14920 1/20 0.41
PARP1 P09874 1/20 0.40
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
TSHR P16473 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
TP53 P04637 2/20 0.36
PLAU P00749 1/20 0.35
GRM5 P41594 1/20 0.35
CTSL P07711 1/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932093 0.73 C1S (0.50) C1SNPC1RAB9APARP1ALDH1A1
SCHEMBL18540697 0.72 C1S (0.57) C1SNPC1RAB9ATDP1PARP1
SCHEMBL18540679 0.70 C1S (0.55) C1SNPC1TDP1PARP1ALDH1A1
SCHEMBL931729 0.70 C1S (0.46) C1SNPC1RAB9APARP1ALDH1A1
SCHEMBL932511 0.69 C1S (0.53) C1SNPC1RAB9APARP1ALDH1A1
SCHEMBL931503 0.69 C1S (0.53) C1SPARP1ALDH1A1TP53CTSL
SCHEMBL3178752 0.69 C1S (0.63) C1SNPC1RAB9APARP1ALDH1A1
SCHEMBL18540642 0.69 PRSS1 (0.49) C1SNPC1RAB9APARP1MAPK1
SCHEMBL931923 0.69 C1S (0.49) C1SNPC1RAB9APARP1ALDH1A1
SCHEMBL933081 0.69 ALOX15 (0.47) C1SNPC1RAB9APARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed